These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 32344058)

  • 21. SARS-CoV-2 and COVID-19: facing the pandemic together as citizens and cardiovascular practitioners.
    Biondi Zoccai G; Landoni G; Carnevale R; Cavarretta E; Sciarretta S; Frati G
    Minerva Cardioangiol; 2020 Apr; 68(2):61-64. PubMed ID: 32150358
    [No Abstract]   [Full Text] [Related]  

  • 22. Initial success in the identification and management of the coronavirus disease 2019 (COVID-19) indicates human-to-human transmission in Wuhan, China.
    Awadasseid A; Wu Y; Tanaka Y; Zhang W
    Int J Biol Sci; 2020; 16(11):1846-1860. PubMed ID: 32398954
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SARS-CoV-2 Infection among Travelers Returning from Wuhan, China.
    Ng OT; Marimuthu K; Chia PY; Koh V; Chiew CJ; De Wang L; Young BE; Chan M; Vasoo S; Ling LM; Lye DC; Kam KQ; Thoon KC; Kurupatham L; Said Z; Goh E; Low C; Lim SK; Raj P; Oh O; Koh VTJ; Poh C; Mak TM; Cui L; Cook AR; Lin RTP; Leo YS; Lee VJM
    N Engl J Med; 2020 Apr; 382(15):1476-1478. PubMed ID: 32163698
    [No Abstract]   [Full Text] [Related]  

  • 24. Are we underestimating seroprevalence of SARS-CoV-2?
    Burgess S; Ponsford MJ; Gill D
    BMJ; 2020 Sep; 370():m3364. PubMed ID: 32883673
    [No Abstract]   [Full Text] [Related]  

  • 25. The Wuhan SARS-CoV-2-What's next for China.
    Lu H; Stratton CW; Tang YW
    J Med Virol; 2020 Jun; 92(6):546-547. PubMed ID: 32115732
    [No Abstract]   [Full Text] [Related]  

  • 26. Imported COVID-19 cases pose new challenges for China.
    Chen L; Cai J; Lin Q; Xiang B; Ren T
    J Infect; 2020 Jun; 80(6):e43-e44. PubMed ID: 32283157
    [No Abstract]   [Full Text] [Related]  

  • 27. Severe Acute Respiratory Syndrome Coronavirus 2 among Asymptomatic Workers Screened for Work Resumption, China.
    Han X; Wei X; Alwalid O; Cao Y; Li Y; Wang L; Shi H
    Emerg Infect Dis; 2020 Sep; 26(9):2265-7. PubMed ID: 32553070
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Providing a laboratory diagnostic service for pandemic SARS-CoV-2 in a developing country.
    Sam IC; Chong J; Kamarudin R; Jafar FL; Lee LM; Bador MK; Chew YY; Tan MP; Chan YF
    Trans R Soc Trop Med Hyg; 2020 Aug; 114(8):553-555. PubMed ID: 32497211
    [No Abstract]   [Full Text] [Related]  

  • 29. Accuracy of the Polymerase Chain Reaction (PCR) test in the diagnosis of acute respiratory syndrome due to coronavirus: a systematic review and meta-analysis.
    Floriano I; Silvinato A; Bernardo WM; Reis JC; Soledade G
    Rev Assoc Med Bras (1992); 2020 Jul; 66(7):880-888. PubMed ID: 32844930
    [No Abstract]   [Full Text] [Related]  

  • 30. [Epidemiology and clinical features of highly pathogenic human coronavirus infection in children].
    Long XR; Zhu J; Zhao RQ; Xu HM
    Zhonghua Er Ke Za Zhi; 2020 May; 58(5):351-354. PubMed ID: 32223839
    [TBL] [Abstract][Full Text] [Related]  

  • 31. COVID-19: A time for renewed recognition of science.
    EBioMedicine; 2020 Jun; 56():102869. PubMed ID: 32580894
    [No Abstract]   [Full Text] [Related]  

  • 32. COVID-19: What Can We Learn From Stories From the Trenches?
    Patlas MN
    Can Assoc Radiol J; 2020 May; 71(2):125-126. PubMed ID: 32129672
    [No Abstract]   [Full Text] [Related]  

  • 33. Cutaneous manifestations related to coronavirus disease 2019 (COVID-19): A prospective study from China and Italy.
    De Giorgi V; Recalcati S; Jia Z; Chong W; Ding R; Deng Y; Scarfi F; Venturi F; Trane L; Gori A; Silvestri F; Gao XH; Lotti T
    J Am Acad Dermatol; 2020 Aug; 83(2):674-675. PubMed ID: 32442696
    [No Abstract]   [Full Text] [Related]  

  • 34. Comparison of Clinical Characteristics of Patients with Asymptomatic vs Symptomatic Coronavirus Disease 2019 in Wuhan, China.
    Yang R; Gui X; Xiong Y
    JAMA Netw Open; 2020 May; 3(5):e2010182. PubMed ID: 32459353
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modeling SARS-CoV-2 Positivity Using Laboratory Data: Timing Is Everything.
    Larson T; Culbreath K; Chavez D; Larson R; Crossey M; Grenache DG
    Clin Chem; 2020 Jul; 66(7):981-983. PubMed ID: 32353116
    [No Abstract]   [Full Text] [Related]  

  • 36. Fighting the Coronavirus Outbreak.
    Kiessling L; Chen P; Wang J; Li JP
    ACS Chem Biol; 2020 Apr; 15(4):799-801. PubMed ID: 32233418
    [No Abstract]   [Full Text] [Related]  

  • 37. An analysis of cancer patients with asymptomatic infection of SARS-CoV-2 in a cancer center in Wuhan, China.
    Yin P; Zeng R; Duan YR; Zhang Y; Kuang XN; Zhang HF; Wei SZ
    Ann Oncol; 2020 Oct; 31(10):1420-1422. PubMed ID: 32710929
    [No Abstract]   [Full Text] [Related]  

  • 38. Pooling of samples for testing for SARS-CoV-2 in asymptomatic people.
    Lohse S; Pfuhl T; Berkó-Göttel B; Rissland J; Geißler T; Gärtner B; Becker SL; Schneitler S; Smola S
    Lancet Infect Dis; 2020 Nov; 20(11):1231-1232. PubMed ID: 32530425
    [No Abstract]   [Full Text] [Related]  

  • 39. Patterns of IgG and IgM antibody response in COVID-19 patients.
    Liu X; Wang J; Xu X; Liao G; Chen Y; Hu CH
    Emerg Microbes Infect; 2020 Dec; 9(1):1269-1274. PubMed ID: 32515684
    [No Abstract]   [Full Text] [Related]  

  • 40. High COVID-19 testing rate in Portugal.
    Triunfol M
    Lancet Infect Dis; 2020 Jul; 20(7):783. PubMed ID: 32592671
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.